Steve Okada

Appearances

USING AN ARTIFICIAL INTELLIGENCE (AI) AND MACHINE LEARNING (ML) PLATFORM TO IDENTIFY MAST CELL FOCUSED THERAPEUTIC TARGETS AND ASSOCIATED GUT-LIVER-BRAIN AXIS INDICATIONS
Date
May 8, 2023
The speakers in this session will provide insights into cutting edge technological advances being applied to basic science and translational research of gastrointestinal diseases…
Speakers
Miles DeAngelis
Madan Anant
Sameer Sharma
Meenakshi Chawla
Ashok Varma
Govindan Vijayadamodar
Sanatan Upmanyu
Anita Ganjoo
Aman Kant
Steve Okada
Krishnan Nandabalan
Presenter
Salvatore Alesci
THE NOVEL AND SPECIFIC CHYMASE INHIBITOR, INVA8001, AMELIORATES THE PHENOTYPES OF PRIMARY SCLEROSING CHOLANGITIS (PSC) IN MDR2<sup>-/-</sup> MICE (MODEL OF PSC) BY DOWNREGULATION OF BILIARY SENESCENCE
Date
May 6, 2023
BACKGROUND: Chronic cholestatic liver diseases, such as primary sclerosing cholangitis (PSC), often lead to end-stage liver disease requiring liver transplantation. PSC also significantly increases the risk of cholangiocarcinoma (CCA)…
Presenter
Jessie Bernard
Speakers
Sameer Sharma
Meenakshi Chawla
Ashok Varma
Lindsey Kennedy
Tianhao Zhou
Debjyoti Kundu
Corinn Marakovits
Lixian Chen
Alison Meyer
Leah Smith
Burcin Ekser
Anita Ganjoo
Aman Kant
Steve Okada
Salvatore Alesci
Krishnan Nandabalan
Gianfranco Alpini
Heather Francis
Indiana University